Compare Trulieve Cannabis Corp. with Similar Stocks
Stock DNA
Other Agricultural Products
CAD 1,646 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.00
-8.95%
1.03
Revenue and Profits:
Net Sales:
409 Million
(Quarterly Results - Dec 2025)
Net Profit:
-63 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.89%
0%
-26.89%
6 Months
-14.37%
0%
-14.37%
1 Year
49.74%
0%
49.74%
2 Years
-46.2%
0%
-46.2%
3 Years
4.07%
0%
4.07%
4 Years
-65.49%
0%
-65.49%
5 Years
-86.7%
0%
-86.7%
Trulieve Cannabis Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
18.80%
EBIT Growth (5y)
36.19%
EBIT to Interest (avg)
3.83
Debt to EBITDA (avg)
1.07
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.67
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.10%
ROCE (avg)
16.66%
ROE (avg)
3.00%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.03
EV to EBIT
7.73
EV to EBITDA
3.62
EV to Capital Employed
1.03
EV to Sales
1.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.38%
ROE (Latest)
-8.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 14 Foreign Institutions (0.1%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
408.80
396.90
3.00%
Operating Profit (PBDIT) excl Other Income
90.70
122.00
-25.66%
Interest
20.50
22.20
-7.66%
Exceptional Items
-14.70
-4.10
-258.54%
Consolidate Net Profit
-62.70
-32.70
-91.74%
Operating Profit Margin (Excl OI)
73.00%
156.90%
-8.39%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 3.00% vs -5.12% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -91.74% vs -49.32% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,650.40
1,625.40
1.54%
Operating Profit (PBDIT) excl Other Income
464.20
369.70
25.56%
Interest
88.70
85.20
4.11%
Exceptional Items
-27.60
-17.70
-55.93%
Consolidate Net Profit
-163.00
-212.20
23.19%
Operating Profit Margin (Excl OI)
134.40%
87.20%
4.72%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 1.54% vs 6.65% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 23.19% vs 63.93% in Dec 2024
About Trulieve Cannabis Corp. 
Trulieve Cannabis Corp.
Other Agricultural Products
Trulieve Cannabis Corp is a Canada-based seed to sale licensed medical cannabis company. The Company cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries), as well as directly to patients through home delivery. It also operates in California, Massachusetts and Connecticut. The Company offers a range of products, such as concentrates, flower, oil, capsules and tinctures. It operates a 35,000 square foot cultivation and processing facility in McKeesport, Pennsylvania. It operates three dispensaries, located in Pittsburgh-area locations and also offers medical marijuana relief solutions for Pennsylvanians certified with serious medical conditions. The Company's subsidiaries include PurePenn LLC, Pioneer Leasing & Consulting LLC and Keystone Relief Centers LLC.






